Curi Bio

About:

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Website: https://www.curibio.com

Twitter/X: curi_bio

Top Investors: National Institutes of Health, DS Asset Management, Dynamk Capital, UTC Investment

Description:

Curi Bio is a biotechnology company that focuses on advancing drug discovery and development through innovative approaches involving human stem cells, systems biology, and data analytics. The company's primary goal is to accelerate the process of identifying and developing new medicines. Curi Bio's platform revolves around the use of human stem cells, which have the potential to be differentiated into various cell types, replicating the behavior of different tissues and organs. This allows researchers to create more accurate and relevant models for studying disease mechanisms and testing potential drug candidates.